Is FEV1 associated with quality of life in children with cystic fibrosis? An original article

被引:0
|
作者
Shirzadi, Rohola [1 ]
Navaei, Safoura [1 ]
Modaresi, Mohammadreza [1 ]
Masiha, Farzad [2 ]
机构
[1] Univ Tehran Med Sci, Childrens Med Ctr, Pediat Resp & Sleep Med Res Ctr, Tehran, Iran
[2] Mazandaran Univ Med Sci, Pediat Infect Dis Res Ctr, Sari, Iran
来源
IMMUNOPATHOLOGIA PERSA | 2020年 / 6卷 / 01期
关键词
Pulmonary function; Cystic fibrosis; Spirometry; Quality of life; LUNG-FUNCTION; WALK TEST; STRESS;
D O I
10.15171/ipp.2020.06
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: Cystic fibrosis (CF) is a serious genetic life-shortening disease. Quality of life (QoL) measurement related to CF children is a relatively new field of research, which includes the patient's perspective in research and clinical practice. Objectives: This study aimed to evaluate the QoL in children with CF and its association with FEV1 (forced expiratory volume in 1 second). Patients and Methods: This cross-sectional study was carried out on 7-14 years old children with CF attending children's medical center from March 2017 to March 2018. Throat swab cultures and spirometry evaluation was performed for all patients. FEV1 was determined and the 6-min walk test (6MWT) was conducted. The patient's psychological status was assessed using the Persian version of pediatric QoL inventory. ANOVA, t test, and chisquare tests were used for data analysis. Results: Seventy-six subjects with the mean age of 10.49 +/- 3.18 years were studied since 59% of them (n=44) were boys. The mean total QoL was 65.34 +/- 17.73. Patients with lower pulmonary function had a lower QoL. There was a significant association between FEV1 and school and emotional functioning (P = 0 .005 and P=0.002, respectively). A significant association was found between SPO2 (peripheral capillary oxygen saturation) reduction after 6MWT and FEV1 decline (P = 0.001). Additionally, a significant association was detected between FEV1 and the distance walked during 6MWT (P = 0.030). Conclusion: Regarding the association between pulmonary function and QoL in CF patients and lower QoL score in our study, the importance of assessing pulmonary function in these patients should not be neglected.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] PEF UNDERESTIMATES FEV1 AND FEV1/FVC PARAMETERS IN CHILDREN AND ADULT POPULATION
    SOLINSKI, M.
    DABROWIECKI, P.
    BASZA, M.
    GORSKA, K.
    KORCZYNSK, P., I
    Koltowski, L.
    CHEST, 2022, 161 (06) : 455A - 455A
  • [42] Impact of elexacaftor/tezacaftor/ivacaftor combination therapy on lung function in adults with cystic fibrosis: Beyond FEV1
    Wollsching-Strobel, M.
    Dieninghoff, D.
    Emrich, L. F.
    Kroppen, D.
    Majorski, D. S.
    Mathes, T.
    Magnet, F. S.
    Schwarz, S. B.
    Criee, C.
    Windisch, W.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [43] Assessing the impact of body mass index on FEV1% and quality of life in asthma patients
    Jain, Sarus
    Golmohamed, Amin
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [44] Impact of elexacaftor/tezacaftor/ivacaftor combination therapy on body plethysmography in adults with cystic fibrosis: Beyond FEV1
    Wollsching-Strobel, Maximilian
    Dieninghoff, Doris
    Mathes, Tim
    Stanzel, Sarah B.
    Criee, Carl-Peter
    Windisch, Wolfram
    Berger, Melanie P.
    PNEUMON, 2024, 37 (02)
  • [45] Understanding FEV1 for the purpose of cystic fibrosis registry comparisons: Does bias in annual review FEV1 affect between-centre comparison within the UK? An analysis of registry data
    Hoo, Zhe Hui
    Campbell, Michael J.
    Walters, Stephen J.
    Wildman, Martin J.
    JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2020, 26 (01) : 229 - 235
  • [46] Correlation of sweat chloride and percent predicted FEV1 in cystic fibrosis patients treated with ivacaftor
    Fidler, Meredith C.
    Beusmans, Jack
    Panorchan, Paul
    Van Goor, Fredrick
    JOURNAL OF CYSTIC FIBROSIS, 2017, 16 (01) : 41 - 44
  • [47] Tracheomalacia Is Associated With Lower FEV1 and Pseudomonas Acquisition in Children With CF
    Fischer, Anthony J.
    Singh, Sachinkumar B.
    Adam, Ryan J.
    Stoltz, David A.
    Baranano, Christopher F.
    Kao, Simon
    Weinberger, Miles M.
    McCray, Paul B., Jr.
    Starner, Timothy D.
    PEDIATRIC PULMONOLOGY, 2014, 49 (10) : 960 - 970
  • [48] Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis
    Dasenbrook, Elliott C.
    Merlo, Christian A.
    Diener-West, Marie
    Lechtzin, Noah
    Boyle, Michael P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 178 (08) : 814 - 821
  • [49] Quality of life is poorly correlated to lung disease severity in school-aged children with cystic fibrosis
    Pattie, Phillip
    Ranganathan, Sarath
    Harrison, Joanne
    Vidmar, Suzanna
    Hall, Graham L.
    Foong, Rachel E.
    Harper, Alana
    Ramsey, Kathryn
    Wurzel, Danielle
    JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (03) : E188 - E203
  • [50] Siblings of children with cystic fibrosis: quality of life and the impact of illness
    Havermans, T.
    Wuytack, L.
    Deboel, J.
    Tijtgat, A.
    Malfroot, A.
    De Boeck, C.
    Proesmans, M.
    CHILD CARE HEALTH AND DEVELOPMENT, 2011, 37 (02) : 252 - 260